AB122 Platform Study

Clinical trial NCT04999761 · RECRUITING

Trial details

NCT number: NCT04999761
Sponsor: Taiho Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumor Pancreatic Ductal Adenocarcinoma Colorectal Cancer Non-small Cell Lung Cancer Gastric Cancer Alveolar Soft Part Sarcoma Esophageal Cancer Head and Neck Cancer Biliary Tract Cancer

Start date: 2021-06-01
Primary completion: 2027-06-01
Enrollment: 917

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.